'Mucormycosis': A Fungal Infection Threatening India During COVID-19' - A Review
Anti-Infective Agents
; 20(1):3-9, 2022.
Article
in English
| ProQuest Central | ID: covidwho-1709079
ABSTRACT
During the second wave of Covid-19 in India, doctors recently reported a outbreak of cases involving a rare infection-called the “black fungus”-among recovering and recovered Covid-19 patients. The frequency of bacterial and fungal coinfections has been continuously rising. At the same time, invasive pulmonary aspergillosis is increasingly being recognized in association with nCOVID-19. Currently, India is suffering from a newly maiming disease associated with nCOVID-19 infected patients;at the time of the treatment, it can be developed into rhino-orbital mucormycosis. There are some approved antifungal therapies for treating this fungal infection. The background, risk factors, and associated reports about the infection are described in this review.
Full text:
Available
Collection:
Databases of international organizations
Database:
ProQuest Central
Language:
English
Journal:
Anti-Infective Agents
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS